Matthias von Herrath, MD: Software Accurately Predicts Optimization of Type 1 Diabetes Treatment
By: Almas Eftekhari
In 2003, a team of leading experts began developing an innovative, virtual means to advance research efforts for type 1 diabetes treatment and prevention. In collaboration with Entelos, Inc. and with funding from the American Diabetes Association, they created the Type 1 Diabetes PhysioLab Platform -- a computer-based model that simulates the pathophysiology of type 1 diabetes in rodents from birth throughout disease progression.
The cutting-edge technology allows scientists to explore alternatives in treatment that are difficult or impractical to measure in laboratory and clinical testing. The model provides key information about when the introduction of treatment would be most effective or when the course of the disease changes. Researchers can then translate the data for human use and predict how people with diabetes may respond to the therapy.
In a study published in the December 2010 issue of Diabetes, Matthias von Herrath, MD. from the La Jolla Institute for Allergy and Immunology confirmed the accuracy of computer modeling in enhancing drug efficacy against type 1 diabetes. Through virtual simulation of nasal insulin therapy, the model revealed critical factors, such as dose timing and frequency that optimize the treatment's effectiveness. Based on the model, Dr. von Herrath implemented the experimental design in his laboratory, and his results verified the model’s successful predictive ability.
"By allowing us to pre-test our theories using computer models, we can ensure that the more time-intensive and costly process of laboratory testing is focused on the most promising therapeutic strategies, with the greatest chance of success," said the senior author.
Dr. von Herrath encourages further development toward a human-based platform to support the design of clinical trials and accelerate treatment goals. "Since early stage human clinical trials can cost $10 million or more, predicting the right conditions to try is important." He envisions that with a human model, "personalized simulations will become possible and customized treatments could be suggested on an individual basis."
(G. Fousteri, J. R. Chan, Y. Zheng, C. Whiting, A. Dave, D. Bresson, M. Croft, M. von Herrath. Virtual Optimization of Nasal Insulin Therapy Predicts Immunization Frequency to Be Crucial for Diabetes Protection. Diabetes, 2010; 59 (12): 3148 DOI: 10.2337/db10-0561)
Check out our parent mentor volunteer program full of parents just like you!
Become a Red Strider! Know someone with diabetes? Walk for them!
Every dollar you give can be doubled until May 15th to help Stop Diabetes!
Scroll through our calendar of EXPOs to find out when there will be one near you.
Ditch the chips! We've got recipes for eight healthy snacks you'll love to eat.
Learn what BIG discounts on auto insurance may await you.
Get motivated with our newly revised “I Hate to Exercise” book
Subscribe to our blog! It’s the best way to see what we’re up to at the Association.
If you have diabetes, join us for the ride!
Order your Diabetes Forecast® today! 25 Tips to healthy living. Click here to start.
Check out our site full of vegetarian meal planning ideas!
Find your local office to get involved in your community.
A new tool to increase the convenience of portion management
Get recipes, tips and more! Join the conversation!
Learn more about Dribble to Stop Diabetes